ACIP drops universal hepatitis B birth dose recommendation / Endpoints
Max Bayer / endpoints - A panel of CDC vaccine advisors has stopped recommending that all children receive the hepatitis B vaccine at birth, overruling scientific consensus and public health officials who pleaded that there was no grounded rationale for ...
#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety
Friday, December 5, 2025, 11:22 am / permalink 16612 / 14 stories in 3 months
A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes / Fierce
fiercehealthcare - Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from 12 former commissioners of the agency.
#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety
Thursday, December 4, 2025, 10:23 am / permalink 16565 / 10 stories in 3 months
UK and US agree zero-tariff deal on pharmaceuticals / ABC News
go - Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least 3 years, in return for the U.K. spending more on new medicines
#healthcare #pharmaceuticals #drugpricing #governmentpolicy
Monday, December 1, 2025, 1:23 pm / permalink 16444 / 6 stories in 3 months
FDA approves all ages gene therapy for spinal condition / Beckers
Ella Jeffries / beckershospitalreview - The FDA approved Novartis’ Itvisma (onasemnogene abeparvovec-brve), the company’s first and only gene replacement therapy for spinal muscular atrophy in children 2 and older, as well as for teens and adults. The therapy is designed to address the genetic …
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda
Monday, December 1, 2025, 4:21 am / permalink 16428 / 2 stories in 3 months
Novo submits high-dose Wegovy for FDA approval using voucher / Endpoints
Max Bayer / endpoints - Novo Nordisk submitted a higher dose of its obesity drug Wegovy for FDA approval and is using a recently-won voucher to expedite the review. The company said Wednesday that it submitted ...
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment #fda
Saturday, November 29, 2025, 5:21 pm / permalink 16400 / 2 stories in 3 months
CASSANDRA-PACT-21 Trial Update: Preoperative PAXG vs mFOLFIRINOX in Resectable and Borderline Resectable PDAC / OncoDaily
oncodaily - The landscape of early-stage pancreatic ductal adenocarcinoma (PDAC) continues to evolve as clinicians move from surgery-first strategies toward perioperative treatment. Neoadjuvant and perioperative approaches have shown growing promise, yet no […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment
Saturday, November 29, 2025, 9:21 am / permalink 16387 / 5 stories in 3 months
Tracking with care: The ethics of using location tracking technology with people living with dementia / Medical Express
medicalxpress - Imagine you're 83 years old, living with dementia in a long-term care home. Lately, your caregivers keep asking you to wear a bracelet on your wrist 24/7. They say it's for your safety, so they can locate you quickly when needed.
Saturday, November 29, 2025, 5:21 am / permalink 16384 / 2 stories in 3 months
Novo Nordisk GLP-1 fails to slow Alzheimer’s in trials / Beckers
Ella Jeffries / beckershospitalreview - Novo Nordisk’s GLP-1 drug semaglutide did not demonstrate a statistically significant effect in slowing progression of Alzheimer’s disease in two late-stage clinical trials. According to a Nov. 24 news release from the company, two double-blinded, placebo…
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment
Tuesday, November 25, 2025, 10:21 am / permalink 16294 / 5 stories in 3 months
FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer / OncoDaily
oncodaily - What Does FDA Approval Mean? The U.S. Food and Drug Administration (FDA) evaluates new cancer therapies to determine whether they are safe and effective for clinical use. Approval is based […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment #fda
Monday, November 24, 2025, 10:23 am / permalink 16257 / 2 stories in 3 months
M. Tezer Kutluk: 2025 Update of World Cancer Declaration with UICC Board / OncoDaily
oncodaily - M. Tezer Kutluk, Professor of Pediatrics and Pediatric Oncologists, Chair of the Scientific Board at Medicana Health Group, shared a post on LinkedIn: “Dear friends, Between 18–20 November 2025 in Melbourne, […]
- Geriatric Oncology Updates (5)
- Global Cancer Leadership & Policy (9)
- Innovative Cancer Treatment & Research (16)
- Other Cancer & Related Topics (17)
Geriatric Oncology Updates
Global Cancer Leadership & Policy
Innovative Cancer Treatment & Research
Other Cancer & Related Topics
Monday, November 24, 2025, 4:21 am / permalink 16241 / 47 stories in 3 months
New nasal nanodrops wipe out brain tumors in mice / Science Daily Cancer
sciencedaily - A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with dru…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, November 22, 2025, 1:21 pm / permalink 16217 / 3 stories in 3 months
Medicare premiums set to rise 10% next year, CMS says / Healthcare Dive
Rebecca Pifer / healthcaredive - The Part B premium hike could have been worse, the Trump administration said. Still, it’s likely to pressure the pocketbooks of millions of seniors, and could drive more into Medicare Advantage plans.
#healthcare #publichealth #governmentpolicy
Saturday, November 22, 2025, 9:22 am / permalink 16211 / 2 stories in 3 months
FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation / ESMO
esmo - Evidence for efficacy is based on the results from the KO-MEN-001 study
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda
Saturday, November 22, 2025, 9:22 am / permalink 16210 / 2 stories in 3 months
New Flu Strain and Low Vaccination Rates Could Mean Aggressive Flu Season Ahead / Discover
discovermagazine - Starting in 2025, this year’s flu season is spreading early, and with vaccination rates low and a novel virus strain, health experts are warning that it could be a rough one.
#healthcare #publichealth #cdc #vaccinesafety
Saturday, November 22, 2025, 5:21 am / permalink 16206 / 4 stories in 3 months
CMS issues new telehealth guidance: 4 notes / Beckers
Giles Bruce / beckershospitalreview - CMS has released updated telehealth guidance following the end of the 43-day government shutdown. Here are four things to know from the November FAQ: 1. CMS will retroactively pay for telehealth claims for services rendered amid the fiscal standoff. 2. Me…
#healthcare #publichealth #governmentpolicy
Saturday, November 22, 2025, 12:21 am / permalink 16202 / 2 stories in 3 months
CMS ups hospital outpatient rates 2.6%, expands site-neutral payments in 2026: 14 notes / Beckers
Alan Condon / beckershospitalreview - CMS on Nov. 21 finalized its Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System rule for 2026, enacting reforms to boost price transparency and expand outpatient access. Fourteen things to know: Hospital outpatien…
#healthcare #publichealth #governmentpolicy
Saturday, November 22, 2025, 12:21 am / permalink 16203 / 2 stories in 3 months
WHO declares end of Indonesia's poliovirus outbreak following yearslong vaccination campaign / Medical Express
medicalxpress - The World Health Organization has declared Indonesia's polio outbreak officially over, following nearly three years of intensive response efforts, officials said Friday.
#healthcare #publichealth #governmentpolicy #vaccinesafety
Saturday, November 22, 2025, 12:21 am / permalink 16201 / 2 stories in 3 months
Healthcare groups decry CDC messaging change on autism and vaccines / Beckers
Mackenzie Bean / beckershospitalreview - Healthcare associations are raising concerns after the CDC this week removed messaging from its website stating that vaccines do not cause autism. The agency updated its webpage on vaccines and autism Nov. 19. Previously, the page said research has shown …
#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #autism
Thursday, November 20, 2025, 5:23 pm / permalink 16158 / 6 stories in 3 months
Novo Nordisk rolls out lower prices for Ozempic and Wegovy / Medical Express
medicalxpress - People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
#obesity #healthcare #pharmaceuticals #drugpricing #novonordisk #weightloss #publichealth #biotech
Thursday, November 20, 2025, 1:22 am / permalink 16131 / 6 stories in 3 months
ESMO AI & Digital Oncology Congress 2025 Closed in Berlin under the Promise of Making the Future of Cancer Care Closer / ESMO
esmo - The European Society for Medical Oncology (ESMO) has just closed its first AI & Digital Oncology Congress, a pioneering moment in the integration of artificial intelligence and digital innovation into cancer care
Monday, November 17, 2025, 8:22 am / permalink 16039 / 6 stories in 3 months